184 related articles for article (PubMed ID: 22220260)
21. JAK2V617F mutation prevalence on Chilean adults suffering from primary mesenteric and portal venous thromboses.
González-Montero J; Del Valle-Batalla L; Castillo-Astorga R; Marín Valdés A; Conte Lanza G
Int J Lab Hematol; 2020 Jun; 42(3):331-334. PubMed ID: 32154655
[TBL] [Abstract][Full Text] [Related]
22. Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis--a concise review.
Shetty S; Ghosh K
Thromb Res; 2011 Jun; 127(6):505-12. PubMed ID: 20961602
[TBL] [Abstract][Full Text] [Related]
23. Splanchnic vein thrombosis, the onset manifestation in JAK positive Chronic Myeloproliferative Disorders Neoplasms.
Vladareanu AM; Popov V; Bumbea H; Onisai M; Ilea A; Dobrea C; Miulescu M
J Med Life; 2011; 4(1):97-101. PubMed ID: 21505581
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors, Diagnosis, Management, and Outcome of Splanchnic Vein Thrombosis: A Retrospective Analysis.
Derman BA; Kwaan HC
Semin Thromb Hemost; 2015 Jul; 41(5):503-13. PubMed ID: 26080303
[TBL] [Abstract][Full Text] [Related]
25. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis.
Qi X; Ren W; De Stefano V; Fan D
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1801-12.e7. PubMed ID: 24793031
[TBL] [Abstract][Full Text] [Related]
26. [Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].
Fama A; Rago A; Gioiosa F; Marzano C; Latagliata R; Mammì C; Laganà C; D'Elia GM; Bizzoni L; Trasarti S; Ferretti A; Breccia M; Riggio O; Tafuri A
Clin Ter; 2010; 161(2):169-71. PubMed ID: 20499034
[TBL] [Abstract][Full Text] [Related]
27. Abdominal thromboses of splanchnic, renal and ovarian veins.
De Stefano V; Martinelli I
Best Pract Res Clin Haematol; 2012 Sep; 25(3):253-64. PubMed ID: 22959542
[TBL] [Abstract][Full Text] [Related]
28. Prothrombotic disorders in abdominal vein thrombosis.
Leebeek FW; Smalberg JH; Janssen HL
Neth J Med; 2012 Nov; 70(9):400-5. PubMed ID: 23123534
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of CALR mutations in splanchnic vein thrombosis: A systematic review and meta-analysis.
Li M; De Stefano V; Song T; Zhou X; Guo Z; Zhu J; Qi X
Thromb Res; 2018 Jul; 167():96-103. PubMed ID: 29803161
[TBL] [Abstract][Full Text] [Related]
30. JAK2 mutations across a spectrum of venous thrombosis cases.
Shetty S; Kulkarni B; Pai N; Mukundan P; Kasatkar P; Ghosh K
Am J Clin Pathol; 2010 Jul; 134(1):82-5. PubMed ID: 20551270
[TBL] [Abstract][Full Text] [Related]
31. The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis.
Smalberg JH; Koehler E; Darwish Murad S; Plessier A; Seijo S; Trebicka J; Primignani M; de Maat MP; Garcia-Pagan JC; Valla DC; Janssen HL; Leebeek FW;
Blood; 2011 Apr; 117(15):3968-73. PubMed ID: 21364191
[TBL] [Abstract][Full Text] [Related]
32. JAK2V617F Mutation in Patient with Splanchnic Vein Thrombosis.
Kumar N; Sharma S; Binota J; Ahluwalia J; Varma N; Naseem S; Chand I; Uppal V; Sinha SK
Indian J Hematol Blood Transfus; 2020 Oct; 36(4):700-704. PubMed ID: 33100713
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis.
Deepak A; Punamiya S; Patel N; Parekh S; Mehta S; Shah N
Trop Gastroenterol; 2011; 32(4):279-84. PubMed ID: 22696908
[TBL] [Abstract][Full Text] [Related]
34. Splanchnic vein thrombosis in the mediterranean area in children.
El-Karaksy H; El-Raziky M
Mediterr J Hematol Infect Dis; 2011; 3(1):e2011027. PubMed ID: 21869913
[TBL] [Abstract][Full Text] [Related]
35. Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study.
Poisson J; Plessier A; Kiladjian JJ; Turon F; Cassinat B; Andreoli A; De Raucourt E; Goria O; Zekrini K; Bureau C; Lorre F; Cervantes F; Colomer D; Durand F; Garcia-Pagan JC; Casadevall N; Valla DC; Rautou PE; Marzac C;
J Hepatol; 2017 Sep; 67(3):501-507. PubMed ID: 28483676
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis.
Mahmoud AE; Elias E; Beauchamp N; Wilde JT
Gut; 1997 Jun; 40(6):798-800. PubMed ID: 9245936
[TBL] [Abstract][Full Text] [Related]
37. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India.
Mohanty D; Shetty S; Ghosh K; Pawar A; Abraham P
Hepatology; 2001 Oct; 34(4 Pt 1):666-70. PubMed ID: 11584361
[TBL] [Abstract][Full Text] [Related]
38. Japanese case of Budd-Chiari syndrome due to hepatic vein thrombosis successfully treated with liver transplantation.
Iwasaki T; Kawai H; Oseki K; Togashi T; Shioji K; Yamamoto S; Sato Y; Suzuki K; Toba K; Nomoto M; Hatakeyama K; Aoyagi Y
Hepatol Res; 2012 Feb; 42(2):213-8. PubMed ID: 22248193
[TBL] [Abstract][Full Text] [Related]
39. The role of thrombophilia in splanchnic vein thrombosis.
Primignani M; Mannucci PM
Semin Liver Dis; 2008 Aug; 28(3):293-301. PubMed ID: 18814082
[TBL] [Abstract][Full Text] [Related]
40. Thrombophilic Genetic Factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A in Noncirrhotic Portal Vein Thrombosis and Budd-Chiari Syndrome in a Caucasian Population.
D'Amico M; Sammarco P; Pasta L
Int J Vasc Med; 2013; 2013():717480. PubMed ID: 24455271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
